GRADE Guidance 34: update on rating imprecision using a minimally contextualized approach
- PMID: 35934265
- DOI: 10.1016/j.jclinepi.2022.07.014
GRADE Guidance 34: update on rating imprecision using a minimally contextualized approach
Abstract
Objectives: The aim of this study is to provide updated guidance on when The Grading of Recommendations Assessment, Development and Evaluation (GRADE) users should consider rating down more than one level for imprecision using a minimally contextualized approach.
Study design and setting: Based on the first GRADE guidance addressing imprecision rating in 2011, a project group within the GRADE Working Group conducted iterative discussions and presentations at GRADE Working Group meetings to produce this guidance.
Results: GRADE suggests aligning imprecision criterion for systematic reviews and guidelines using the approach that relies on thresholds and confidence intervals (CI) of absolute effects as a primary criterion for imprecision rating (i.e., CI approach). Based on the CI approach, when a CI appreciably crosses the threshold(s) of interest, one should consider rating down two or three levels. When the CI does not cross the threshold(s) and the relative effect is large, one should implement the optimal information size (OIS) approach. If the sample size of the meta-analysis is far less than the OIS, one should consider rating down more than one level for imprecision.
Conclusion: GRADE provides updated guidance for imprecision rating in a minimally contextualized approach, with a focus on the circumstances in which one should seriously consider rating down two or three levels for imprecision.
Keywords: GRADE; Guideline; Imprecision; Minimally contextualized approach; Systematic review.
Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.
Similar articles
-
GRADE guidance 37: rating imprecision in a body of evidence on test accuracy.J Clin Epidemiol. 2024 Jan;165:111189. doi: 10.1016/j.jclinepi.2023.10.005. Epub 2023 Oct 28. J Clin Epidemiol. 2024. PMID: 38613246
-
GRADE guidance 35: update on rating imprecision for assessing contextualized certainty of evidence and making decisions.J Clin Epidemiol. 2022 Oct;150:225-242. doi: 10.1016/j.jclinepi.2022.07.015. Epub 2022 Aug 5. J Clin Epidemiol. 2022. PMID: 35934266
-
GRADE guidelines 32: GRADE offers guidance on choosing targets of GRADE certainty of evidence ratings.J Clin Epidemiol. 2021 Sep;137:163-175. doi: 10.1016/j.jclinepi.2021.03.026. Epub 2021 Apr 20. J Clin Epidemiol. 2021. PMID: 33857619
-
Challenges in applying the GRADE approach in public health guidelines and systematic reviews: a concept article from the GRADE Public Health Group.J Clin Epidemiol. 2021 Jul;135:42-53. doi: 10.1016/j.jclinepi.2021.01.001. Epub 2021 Jan 18. J Clin Epidemiol. 2021. PMID: 33476768 Free PMC article.
-
[How to interpret the certainty of evidence based on GRADE (Grading of Recommendations, Assessment, Development and Evaluation)].Urologe A. 2021 Apr;60(4):444-454. doi: 10.1007/s00120-021-01471-2. Epub 2021 Feb 23. Urologe A. 2021. PMID: 33620513 Review. German.
Cited by
-
Device-supported automated basal insulin titration in adults with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.Lancet Reg Health West Pac. 2023 Mar 24;35:100746. doi: 10.1016/j.lanwpc.2023.100746. eCollection 2023 Jun. Lancet Reg Health West Pac. 2023. PMID: 37424694 Free PMC article.
-
The impact of blinding on trial results: A systematic review and meta-analysis.Cochrane Evid Synth Methods. 2023 Jun 20;1(4):e12015. doi: 10.1002/cesm.12015. eCollection 2023 Jun. Cochrane Evid Synth Methods. 2023. PMID: 40475370 Free PMC article. Review.
-
Silymarin for adults with metabolic dysfunction-associated steatotic liver disease.Cochrane Database Syst Rev. 2025 Jun 24;6(6):CD015524. doi: 10.1002/14651858.CD015524.pub2. Cochrane Database Syst Rev. 2025. PMID: 40552569
-
Vitamin E for people with non-alcoholic fatty liver disease.Cochrane Database Syst Rev. 2024 Oct 16;10(10):CD015033. doi: 10.1002/14651858.CD015033.pub2. Cochrane Database Syst Rev. 2024. PMID: 39412049 Free PMC article.
-
Safety and efficacy of beta-3 adrenergic agonists in treating neurogenic lower urinary tract dysfunction: A systematic review and meta-analysis.Investig Clin Urol. 2024 May;65(3):217-229. doi: 10.4111/icu.20230271. Investig Clin Urol. 2024. PMID: 38714512 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources